Search

Author/Creator Yoshitomi, S.

1. 134P Safety and efficacy of eribulin and trastuzumab in anti-HER2 therapy pretreated patients with HER2-positive metastatic breast cancer: A Japanese multicenter phase 2 study (SBP-04 study). (20th December 2016)

Authors:
Shien, T.; Ikeda, M.; Ohtani, S.; Hara, F.; Takahashi, M.; Tuji, H.; Yoshitomi, S.; Matsuoka, K.; Ogasawara, Y.; Taira, N.; Doihara, H.; Ohsumi, S.
Journal:
Annals of oncology
Issue:
Volume 27(2016:Sep.)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Novel biallelic SZT2 mutations in 3 cases of early‐onset epileptic encephalopathy. Issue 2 (18th September 2017)

Authors:
Tsuchida, N.; Nakashima, M.; Miyauchi, A.; Yoshitomi, S.; Kimizu, T.; Ganesan, V.; Teik, K.W.; Ch'ng, G.‐S.; Kato, M.; Mizuguchi, T.; Takata, A.; Miyatake, S.; Miyake, N.; Osaka, H.; Yamagata, T.; Nakajima, H.; Saitsu, H.; Matsumoto, N.
Journal:
Clinical genetics
Issue:
Volume 93:Issue 2(2018)
Page Start:
266
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗